The Global Active Pharmaceutical Ingredient Market- Industry Analysis, Share, Trend, Market Size and Forecast was estimated to be around US$ 151.6 billion in 2019 and is anticipated to grow with 6.0% of growth rate during the future period.
The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro-markets, the report also focuses on industry-specific drivers, restraints and opportunities in the Active
Pharmaceutical Ingredient market. In terms of manufacturer segments of the Active Pharmaceutical Ingredient market Captive API market was the largest segment in 2015, and is expected to lose its share to merchant API market largely due to shift in trend towards CMOs for API production. Based on synthesis, Synthetic API was the largest segment for Active pharmaceutical ingredient market by synthesis in 2015, but is expected to lose its share to biological API largely due to increasing demand of biosimilars. However, large investment in specialized containment and limited improvement in pharmaceutical facilities may reduce overall growth.
COVID-19 Impact & Recovery Analysis
The proposed report from AnalystView Market Insights suggests three possible forecast scenarios (probable, optimistic, and pessimistic) considering the COVID-19 impact. Our ongoing research analysis amplifies our framework to ensure the inclusion of underlying COVID-19 crisis impact and potential paths forward. The designed report is delivering detailed insights on COVID-19 considering the changes in consumer demand, purchasing patterns, re-routing of the supply chain, and the significant interventions of governments. The updated study provides insights, and forecast, considering the COVID-19 impact on the market.
Companies reported in this report are: Pfizer,Inc, Boehringer Ingelheim GmbH, Cambrex Corporation, Novartis AG, Lonza Group, Mylan N.V. and others. For company profiles in the report, 2014 has been considered. Where information is unavailable for the base year, the prior year has been considered.
The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.
The years considered for the study are:
Historical Year 2016 to 2018
Base Year 2019
Estimated Year 2020
Projected Year 2027
The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.
The research report categorizes the Active Pharmaceutical Ingredient Market in each of the following submarkets to forecast the revenues and analyze the trends:
GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY MANUFACTURER
Captive
Merchant
GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY SYNHESIS
Synthetic
Biological
GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY DRUG TYPE
Generic
Branded
GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY THERAPEUTIC AREA
Cardiovascular
Metabolic
CNS
Oncology
Musculoskeletal
NSAIDS
Others
GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT MARKET, BY REGION
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
TABLE OF CONTENT ACTIVE PHARMACEUTICAL INGREDIENT MARKET OVERVIEW
Study Scope
Base Year
Assumption and Methodology
EXECUTIVE SUMMARY
Key Market Facts
Geographical Scenario
Companies in the Market
PHOTODYNAMIC THERAPY KEY MARKET TRENDS
Market Drivers
Impact Analysis of Market Drivers
Market Restraints
Impact Analysis of Market Restraints
Market Opportunities
Market Future Trends
PHOTODYNAMIC THERAPY INDUSTRY STUDY
Company Activity Analysis
Regulatory Framework Analysis
Value Chain Analysis
ACTIVE PHARMACEUTICAL INGREDIENT MARKET LANDSCAPE
Market Share Analysis
Key Innovators
ACTIVE PHARMACEUTICAL INGREDIENT MARKET BY MANUFACTURER:
Overview
Captive
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Merchant
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
ACTIVE PHARMACEUTICAL INGREDIENT MARKET BY SYNHESIS:
Overview
Synthetic
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Biological
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
ACTIVE PHARMACEUTICAL INGREDIENT MARKET BY DRUG TYPE:
Overview
Generic
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Branded
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
ACTIVE PHARMACEUTICAL INGREDIENT MARKET BY THERAPEUTIC AREA:
Overview
Cardiovascular
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Metabolic
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
CNS
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Oncology
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Musculoskeletal
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
NSAIDS
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Others
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
ACTIVE PHARMACEUTICAL INGREDIENT MARKET BY GEOGRAPHY
Introduction
North America
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
S.
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Canada
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Europe
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
France
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Germany
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Rest of Europe
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Asia Pacific (APAC)
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
China
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
India
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Rest of APAC
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Rest of the World
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Latin America
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
Middle East and Africa
Overview
Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 2027, (US$ Million)
KEY VENDOR ANALYSIS
Pfizer, Inc.
Company Overview
SWOT Analysis
Key Developments
Mylan
Company Overview
SWOT Analysis
Key Developments
Novartis
Company Overview
SWOT Analysis
Key Developments
Boehringer Ingelheim GmbH
Company Overview
SWOT Analysis
Key Developments
Lonza
Company Overview
SWOT Analysis
Key Developments
Aurobindo
Company Overview
SWOT Analysis
Key Developments
360 DEGREE ANALYSTVIEW
APPENDIX
Research Methodology
Abbreviations
Disclaimer
Contact Us
SCOPE AND OBJECTIVES
The objective of this report is to describe the market trends and revenue forecasts for the Active Pharmaceutical Ingredient Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.
The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the Active Pharmaceutical Ingredient Market by its major segments, which include the type, end user industry, and the major geographic regions.
KEY BENEFITS OF THE REPORT:
Understanding of the strategies that are being adopted by the key players in this market to stay competitive
Extensive analysis of the key players dominating the competitive landscape of this market
In-depth analysis of the key factors are propelling the growth of the global market
Detailed analysis of the geographic region that will witness the strongest growth
Granular analysis of the current market scenario and the expected market grow
KEY PREMIUM INSIGHTS:
Consistent increase in demand of API from developing world for better medical care
API Industry witness increase in the number of innovator companies using CDMOs with HPAPI capabilities. The strong demand for such capability services is having significant demand on contract manufacturing market. Many companies are busy in expanding their existing facilities others sought to acquire business with HPAPI capabilities.
Rapid shift towards biological augmented to complexity of manufacturing requirements and difficult to replicate as compared to chemical APIs. Biological drugs are gaining more and more popularity in the treatment of chronic diseases primarily in oncology, cardiology, neurology and other conditions.